AU Patent

AU2024318251A1 — Oral formulations of cannabinoids

Assigned to University of Toronto · Expires 2026-03-19 · 0y expired

What this patent protects

The present disclosure provides formulations of cannabinoid with advantages such as high drug-loading and stability, and related methods of manufacturing and using the formulations.

USPTO Abstract

The present disclosure provides formulations of cannabinoid with advantages such as high drug-loading and stability, and related methods of manufacturing and using the formulations.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024318251A1
Jurisdiction
AU
Classification
—
Expires
2026-03-19
Drug substance claim
No
Drug product claim
No
Assignee
University of Toronto
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.